SR&ED Consultants for Life Sciences & Biotech

Life sciences and biotechnology companies are among the highest-value SR&ED claimants in Canada. The inherent uncertainty in drug development, medical device design, diagnostics creation, and biological research aligns closely with the SR&ED program's eligibility criteria. From early-stage discovery through preclinical trials, companies invest heavily in systematic investigation that the CRA recognizes as eligible R&D. Canadian biotech firms benefit from both federal and provincial SR&ED credits, often combining them with other government funding programs like IRAP and provincial innovation grants.